Advances in clinical application of glucocorticoid in prevention and treatment of BPD of preterm infants / 国际儿科学杂志
International Journal of Pediatrics
;
(6): 628-632, 2021.
Artigo
em Chinês
| WPRIM
| ID: wpr-907292
ABSTRACT
Bronchopulmonary dysplasia is a chronic lung disease unique to premature infants, which has a great impact on the survival and long-term quality of life of preterm infants.At present, there are no specific prevention and treatment methods for BPD.The clinical treatment is mainly comprehensive.Glucocorticoids are the most widely used in clinical practice.The drugs mainly include dexamethasone, hydrocortisone and budenonide.The route of administration includes intravenous administration, aerosol inhalation, intratracheal infusion combined with pulmonary surfactants, but its efficacy and possible adverse reactions need to be weighed.This article reviews the different results by different administration routes and dose of glucocorticoids.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
International Journal of Pediatrics
Ano de publicação:
2021
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS